Stryker vs. Zimmer Biomet vs. Johnson & Johnson: How they compare in Q4 2023

Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter financial results for 2023 and data on their orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $5.8 billion (+11.8%)

Orthopedics: $2.4 billion (+11%)

Hips: $414 million (+10.2%)

Knees: $630 million (+14.2%)

Spine: $318 million (+7%)

Zimmer Biomet

Total sales: $1.9 billion (+6.3%)

Hips: $504.8 million (+3.3%)

Knees: $798.3 million (+5.9%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $453.3 million (+6.9%)

Johnson & Johnson

Total sales: $21.4 billion (+7.3%)

Spine, sports and other: $742 million (+6.2%)

Orthopedic: $2.3 billion (+5.6%)

Hips: $398 million (+3.4%)

Knees: $387 million (+9.2%)

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.